| |
|
|
|
Kazia Therapeutics Ltd  
|
|
10.08 -0.41 (-0.04%) |
01-25 16:00 |
|
Open: |
10.76 |
Pre close: |
10.49 |
Target:
|
12.94
|
|
High: |
10.76 |
Low: |
10.08 |
Resistance:
|
11.08
12.69
|
|
Volume: |
136,392 |
Market Cap: |
99M |
Support:
|
8.48
7.06
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.52
 |
MACD |
MACD(12,26):
|
0.36 |
|
MA(20): |
9.74  |
Signal(12,26,9): |
0.30 |
|
MA(100): |
8.08 |
Stochastic Oscillator |
%K(14,3):
|
53.71 |
|
MA(250): |
5.49 |
%D(3): |
68.42 |
|
Average Volume(K) |
3-Month: |
53829
|
52-Week |
High:
|
15.85 |
|
10-Days: |
17556 |
Low: |
2.47 |
|
RSI |
RSI(14):
|
52.41 |
Change(%): |
140.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.920 |
Return on Equity (ttm) |
-88.0 |
Shares Out. (M) |
9.46 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-34.5 |
Shares Float (M) |
6.26 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-46.1 |
% Held by Institutions |
7.86 |
|
Forward EPS |
-1.258 |
Gross Profit (p.s.) |
0.104 |
Shares Short (K) |
22 |
|
Book Value (p.s.) |
2.940 |
EBITDA (p.s.) |
0.000 |
P/E |
-10.96 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.43 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
